Cargando…

The incidence and risk factors for allogenic blood transfusion in total knee and hip arthroplasty

BACKGROUND: Excessive blood loss in total joint arthroplasty (TJA) usually leads to an allogenic blood transfusion, which may cause adverse outcomes, prolonged length of hospitalization, and increased costs. The purpose of this study was to determine the incidence and risk factors for intraoperative...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Kai, Pan, Pin, Yao, Yao, Jiang, Tao, Jiang, Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712778/
https://www.ncbi.nlm.nih.gov/pubmed/31455380
http://dx.doi.org/10.1186/s13018-019-1329-0
_version_ 1783446749497524224
author Song, Kai
Pan, Pin
Yao, Yao
Jiang, Tao
Jiang, Qing
author_facet Song, Kai
Pan, Pin
Yao, Yao
Jiang, Tao
Jiang, Qing
author_sort Song, Kai
collection PubMed
description BACKGROUND: Excessive blood loss in total joint arthroplasty (TJA) usually leads to an allogenic blood transfusion, which may cause adverse outcomes, prolonged length of hospitalization, and increased costs. The purpose of this study was to determine the incidence and risk factors for intraoperative and postoperative allogenic transfusion in patients undergoing primary unilateral total knee and hip arthroplasty (TKA and THA). METHODS: We conducted a retrospective study and enrolled consecutive patients undergoing primary unilateral TKA and THA at our institution between January 2010 and July 2014 (n = 1534). Information about allogenic transfusion was collected from medical records to determine the incidence. We performed univariate analysis and multivariate logistic regression analysis to identify the independent risk factors. RESULTS: Total, intraoperative, and postoperative transfusion rates were 17.9%, 7.9%, and 11.3%, respectively. The preoperative lower level of hemoglobin (Hb) (P < 0.001) and increased amount of intraoperative blood loss (P < 0.001) were independently associated with transfusion in TKA. The independent risk factors for transfusion in THA were female (P = 0.023), preoperative lower Hb level (P < 0.001), prolonged operation time (P < 0.001), and increased intraoperative blood loss (P < 0.001). CONCLUSIONS: Given the high prevalence and potential risk of transfusion in TJA, interventions for identified risk factors should be used during the perioperative period.
format Online
Article
Text
id pubmed-6712778
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-67127782019-08-29 The incidence and risk factors for allogenic blood transfusion in total knee and hip arthroplasty Song, Kai Pan, Pin Yao, Yao Jiang, Tao Jiang, Qing J Orthop Surg Res Research Article BACKGROUND: Excessive blood loss in total joint arthroplasty (TJA) usually leads to an allogenic blood transfusion, which may cause adverse outcomes, prolonged length of hospitalization, and increased costs. The purpose of this study was to determine the incidence and risk factors for intraoperative and postoperative allogenic transfusion in patients undergoing primary unilateral total knee and hip arthroplasty (TKA and THA). METHODS: We conducted a retrospective study and enrolled consecutive patients undergoing primary unilateral TKA and THA at our institution between January 2010 and July 2014 (n = 1534). Information about allogenic transfusion was collected from medical records to determine the incidence. We performed univariate analysis and multivariate logistic regression analysis to identify the independent risk factors. RESULTS: Total, intraoperative, and postoperative transfusion rates were 17.9%, 7.9%, and 11.3%, respectively. The preoperative lower level of hemoglobin (Hb) (P < 0.001) and increased amount of intraoperative blood loss (P < 0.001) were independently associated with transfusion in TKA. The independent risk factors for transfusion in THA were female (P = 0.023), preoperative lower Hb level (P < 0.001), prolonged operation time (P < 0.001), and increased intraoperative blood loss (P < 0.001). CONCLUSIONS: Given the high prevalence and potential risk of transfusion in TJA, interventions for identified risk factors should be used during the perioperative period. BioMed Central 2019-08-28 /pmc/articles/PMC6712778/ /pubmed/31455380 http://dx.doi.org/10.1186/s13018-019-1329-0 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Song, Kai
Pan, Pin
Yao, Yao
Jiang, Tao
Jiang, Qing
The incidence and risk factors for allogenic blood transfusion in total knee and hip arthroplasty
title The incidence and risk factors for allogenic blood transfusion in total knee and hip arthroplasty
title_full The incidence and risk factors for allogenic blood transfusion in total knee and hip arthroplasty
title_fullStr The incidence and risk factors for allogenic blood transfusion in total knee and hip arthroplasty
title_full_unstemmed The incidence and risk factors for allogenic blood transfusion in total knee and hip arthroplasty
title_short The incidence and risk factors for allogenic blood transfusion in total knee and hip arthroplasty
title_sort incidence and risk factors for allogenic blood transfusion in total knee and hip arthroplasty
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712778/
https://www.ncbi.nlm.nih.gov/pubmed/31455380
http://dx.doi.org/10.1186/s13018-019-1329-0
work_keys_str_mv AT songkai theincidenceandriskfactorsforallogenicbloodtransfusionintotalkneeandhiparthroplasty
AT panpin theincidenceandriskfactorsforallogenicbloodtransfusionintotalkneeandhiparthroplasty
AT yaoyao theincidenceandriskfactorsforallogenicbloodtransfusionintotalkneeandhiparthroplasty
AT jiangtao theincidenceandriskfactorsforallogenicbloodtransfusionintotalkneeandhiparthroplasty
AT jiangqing theincidenceandriskfactorsforallogenicbloodtransfusionintotalkneeandhiparthroplasty
AT songkai incidenceandriskfactorsforallogenicbloodtransfusionintotalkneeandhiparthroplasty
AT panpin incidenceandriskfactorsforallogenicbloodtransfusionintotalkneeandhiparthroplasty
AT yaoyao incidenceandriskfactorsforallogenicbloodtransfusionintotalkneeandhiparthroplasty
AT jiangtao incidenceandriskfactorsforallogenicbloodtransfusionintotalkneeandhiparthroplasty
AT jiangqing incidenceandriskfactorsforallogenicbloodtransfusionintotalkneeandhiparthroplasty